CLOV

Clover Health Investments Corp. Class A Common Stock (CLOV)

Stock · NASDAQ · Health Care

$4.49as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.

Active signals

Resistance level
$4.54
Industry
Medical Specialities

What CLOV's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike36+1.4%53%
Bollinger Band Breakout25-2.4%48%
Bollinger Band Breakdown21+2.9%52%
200-Day Moving Average TouchActive now8-6.6%38%
Any 20-session window (baseline)-2.6%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Sector
Health Care
Industry
Medical Specialities
Employees
724

Fundamentals

1-day range
$4.61$4.76
Market cap
$2.45B
P/E (trailing)
—
P/E (forward)
30.87
EPS (trailing)
$-0.04
Dividend yield
—
Beta
2.53
Avg. volume
4.30M
52-week range
$1.58$5.59
Next earnings: November 4, 2026 · EPS estimate $0.01confirmed

How Clover Health Investments Corp. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.92BOther$1.71B (89%)SG&A$214.27M (11%)CLOV

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Operating Income-$85.53M(-4%)

Forecasts

4 analyst ratings

Buy 60%
Hold 40%
Sell 0%
1-year price forecast
High
$6
+33.8%
Median
$5.25
+17.1%
Low
$5
+11.5%

Clover Health Investments Corp. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • CLOV
    Clover Health Investments Corp. Class A Common Stock
    $4.48
    ▼ 4.27%
    Market cap $2.45BP/E —
    $1.58$5.59
  • CDNA
    CareDx Inc. Common Stock
    $64
    ▼ 4.01%
    Market cap $2.32BP/E 31.07
    $14.03$72.51
  • GRAL
    GRAIL Inc. Common Stock
    $117.81
    ▼ 13.03%
    Market cap $2.72BP/E —
    $41.5$166.48
  • ALHC
    Alignment Healthcare Inc. Common Stock
    $8.28
    ▲ 1.60%
    Market cap $2.78BP/E 41.54
    $6.01$25.12
  • ACHC
    Acadia Healthcare Company Inc. Common Stock
    $29.98
    ▼ 3.41%
    Market cap $2.86BP/E —
    $11.43$35.83
  • FTRE
    Fortrea Holdings Inc. Common Stock
    $22.49
    ▼ 1.12%
    Market cap $1.68BP/E —
    $8.55$23.51
  • PSNL
    Personalis Inc. Common Stock
    $15.65
    ▼ 1.76%
    Market cap $1.39BP/E —
    $4.96$18.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
188.0K
Disposed
776.3K

Institutional Ownership

March 31, 2026

Total shares held
126.94M
Total value held
$218.26M
Institutional holders
203
Top holders this quarter
  • Unknown31.84M
  • Unknown16.98M
  • Unknown10.06M
  • Unknown9.56M
  • Unknown5.30M
  • Unknown5.09M
  • Unknown3.76M
  • Unknown3.42M
  • Unknown3.40M
  • Unknown3.36M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.